At Monash, we’re conducting world-leading, clinically-driven neurobionics research aimed at improving the treatment of neurological disorders. This includes restoring sight to the blind, restoring movement to limbs paralysed by spinal cord injury and developing new treatments for epilepsy.
Neurobionics draws on the skills and experience of researchers across the disciplines of neurophysiology, electrical engineering, materials science, manufacturing, communications technologies, computer vision, machine learning, neurosurgery and neuroscience. We work closely with industry to ensure our research has the best potential for clinical translation and commercialisation, building in early consideration of regulatory requirements into our development of prototypes, and the future transition to product design and clinical trials.
Monash University’s research successes in neurobionics include the development of Monash Vision Group’s bionic vision system, creation of new functional biomaterials to assist in the repair of damaged neural pathways in the brain, fundamental discoveries into how our brains control vision and movement, and sophisticated decoding algorithms to extract movement intentions from brain signals.